MiR-1224 Acts as a Prognostic Biomarker and Inhibits the Progression of Gastric Cancer by Targeting SATB1

OBJECTIVE: MiR-1224 has been reported to exhibit abnormal expression in several tumors. However, the expressing pattern and roles of miR-1224 in gastric cancer (GC) remain unclear. Our current research aimed to explore the potential involvement of miR-1224 in the GC progression. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Guo-Dong, Sun, Yuan, Hui, Hong-Xia, Tao, Ming-Yue, Liu, Yang-Qing, Zhu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484804/
https://www.ncbi.nlm.nih.gov/pubmed/34604093
http://dx.doi.org/10.3389/fonc.2021.748896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484804/
https://www.ncbi.nlm.nih.gov/pubmed/34604093
http://dx.doi.org/10.3389/fonc.2021.748896

Ejemplares similares